Minoxidil, > = 99 %(TLC)

Non disponible en dehors du Royaume-Uni et de l'Irlande

Application

Minoxidil has been used as test drug:in dermal papilla spheroid model, to study the effect of hair regenerationadministered orally to experimental rats, in the approach to identify biomarkers of drug induced vascular injuryadministered via oral gavage to nonhuman primate model in order to study its effect on tilt responses

Biochem/physiol Actions

Minoxidil is originally used to treat hypertension, which also induces hypertrichosis. It is considered as a potent drug for treating androgenetic alopecia.

Activates ATP-activated K⁺ channels; vasodilator; slow or stop hair loss and promote hair regrowth.

Features and Benefits

This compound was developed by Johnson & Johnson. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

This compound is featured on the Potassium Channels page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here.